| Kristin R Cunningham, PMHNP | |
|
1045 E 23rd St, Lawrence, KS 66046-5003 | |
| (785) 393-6167 | |
| Not Available |
| Full Name | Kristin R Cunningham |
|---|---|
| Gender | Female |
| Speciality | Psychiatry & Neurology - Psychiatry |
| Location | 1045 E 23rd St, Lawrence, Kansas |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1528773512 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 53-81805-062 (Kansas) | Primary |
| Entity Name | Interpersonal Psychiatry Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1134556087 PECOS PAC ID: 9739310343 Enrollment ID: O20140325000801 |
News Archive
The work deepens understanding of an autistic brain's function and may one day inform new treatment approaches and augment how teachers interact with their autistic students.
Georgetown Lombardi Comprehensive Cancer Center, part of Georgetown University Medical Center, announces the launch of the Georgetown Database of Cancer or G-DOC. Under development for two years, G-DOC is a repository for biological information that is normally only available in scattered information libraries and tissue banks, if at all. Data sets grow as researchers deposit new information. G-DOC also contains relevant tools to analyze the data, plus new ones not seen before.
Bellicum Pharmaceuticals, Inc. today announced $4.5 million in Series A and Convertible Note funding. The new funds will be used to complete the company's ongoing Phase I/IIa trial of BP-GMAX-CD1 in patients with advanced, androgen independent prostate cancer, and to prepare for Phase IIb trials. The company anticipates reporting initial results of the Phase I/IIa trial in mid 2010.
Scientists are reporting refinement of a new test that promises to help assure the safety of supplies of heparin, the blood thinner taken by millions of people worldwide each year to prevent blood clots.
Novavax, Inc. today presented to the world's leading pandemic influenza vaccine experts a summary of the recent preliminary safety and immunogenicity data from its Pivotal 2009 A/H1N1 VLP pandemic influenza vaccine study in Mexico.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kristin R Cunningham, PMHNP 1045 E 23rd St, Lawrence, KS 66046-5003 Ph: (785) 393-6167 | Kristin R Cunningham, PMHNP 1045 E 23rd St, Lawrence, KS 66046-5003 Ph: (785) 393-6167 |
News Archive
The work deepens understanding of an autistic brain's function and may one day inform new treatment approaches and augment how teachers interact with their autistic students.
Georgetown Lombardi Comprehensive Cancer Center, part of Georgetown University Medical Center, announces the launch of the Georgetown Database of Cancer or G-DOC. Under development for two years, G-DOC is a repository for biological information that is normally only available in scattered information libraries and tissue banks, if at all. Data sets grow as researchers deposit new information. G-DOC also contains relevant tools to analyze the data, plus new ones not seen before.
Bellicum Pharmaceuticals, Inc. today announced $4.5 million in Series A and Convertible Note funding. The new funds will be used to complete the company's ongoing Phase I/IIa trial of BP-GMAX-CD1 in patients with advanced, androgen independent prostate cancer, and to prepare for Phase IIb trials. The company anticipates reporting initial results of the Phase I/IIa trial in mid 2010.
Scientists are reporting refinement of a new test that promises to help assure the safety of supplies of heparin, the blood thinner taken by millions of people worldwide each year to prevent blood clots.
Novavax, Inc. today presented to the world's leading pandemic influenza vaccine experts a summary of the recent preliminary safety and immunogenicity data from its Pivotal 2009 A/H1N1 VLP pandemic influenza vaccine study in Mexico.
› Verified 2 days ago
Timothy Jason Mccord, D.O. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 200 Maine St Ste A, Lawrence, KS 66044 Phone: 785-843-9192 Fax: 785-856-9191 | |
Dr. Sanjeev Kumar, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1130 W 4th St Ste 3203, Lawrence, KS 66044 Phone: 785-832-1424 Fax: 785-505-5260 | |
Dr. Linda Lorene Keeler, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 1200 Schwegler Dr, Watkins Health Center 2100, Lawrence, KS 66045 Phone: 785-864-2277 Fax: 785-864-2721 | |
Joe Douglas, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 200 Maine, Suite A, Lawrence, KS 66044 Phone: 785-843-9192 Fax: 785-856-9191 | |
Dr. John D Clark, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1130 W 4th St Ste 3203, Lawrence, KS 66044 Phone: 785-830-8324 Fax: 785-505-5260 | |
Dr. Paul D Morte, D.O. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 1112 W 6th St, Ste 218, Lawrence, KS 66044 Phone: 785-842-8240 Fax: 785-842-7474 | |
Dr. C. Shaffia Laue, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 1025 Kentucky St, Lawrence, KS 66044 Phone: 785-841-1243 Fax: 785-841-1243 |